IN PARTNERSHIP
Advantage 3: Faster start-up and reduced time to end of study On separate systems, study start-up can often take four to six months to make time for co- ordinating schedules with multiple vendors and working out integration requirements. A single vendor delay can seriously impact an entire study timeline, especially for trials on a global scale. Study close-outs can also be delayed if your team is spending valuable time on manual tracking and reconciliation of data between modules on separate systems.
When working with a single, powerful, unified platform for critical modules, there are fewer vendors to coordinate and mobilise. Fusion’s rapid study start-up process means time to first person in can be reduced to 30 – 60 days if all your study modules are already integrated and deployed by a single vendor. Real-time data syncing across unified modules also means eliminating manual work required and faster study close-outs.
Advantage 4: Automating key tasks and study-wide notifications
Manual tasks are not only time-consuming but also prone to human error. Tasks such as keeping track of clinical trial materials (CTM) supply and managing cohort assignments may require constant manual monitoring of notifications and comparing statuses across modules.
A unified system inherently supports study-wide data integration and notifications informed by shared data across modules and automated tasks, triggered by alerts in real-time. One example of multiple key modules working together seamlessly is Fusion’s AI-driven Inventory Auto Resupply feature. Bringing together data from RTSM/ IWRS, CTM tracking and ePRO modules, Fusion is able to accurately capture each site’s current inventory, including materials in transit and pending site receipt, upcoming expiries, and accountability or returns. Inventory thresholds set at a site level are then adjusted in real-time for buffer and safety stock, and the AI will predict upcoming resupply needs based on historical and scheduled activity. Aside from setting thresholds at study start-up, everything is executed and documented automatically.
Advantage 5: Reduce the risks across your study When your study faces new challenges
or requirements presented by evolving circumstances, another benefit of a unified platform is the elimination of the risks associated with creating data pipes between different systems. In addition, every time you merge data across different systems, you introduce a new set of risks in the validation of the integrations.
Advantage 6: Lower costs and reduction in team resources required Working with multiple systems is not only complicated from a budgeting perspective, with multiple vendors and contracts, but also in terms of tasking for study teams who must learn how to use the systems themselves. Your team will likely need to log on to multiple systems on a regular basis to download reports and monitor activities. Duplicate data entry for non-integrated data points can also be a time-consuming task. Payment management in clinical studies is a great example of where hundreds of hours are spent managing manual reconciliation between different systems just to pay sites what they are owed. Imagine the possibilities of eliminating payment reconciliation in your studies. How many hours would that save your teams? A fully unified platform eliminates data
integration costs and reduces the resources needed from your study team to juggle multiple log-ons and reconcile data. Along with giving all project stakeholders real-time custom-level access to your study data, Fusion’s end-users are all supported by the same customer care team who have in-depth knowledge of all modules on the platform, as well as your entire study setup. In the long term, your team can also reuse Fusion study configurations for future projects. Celebrating 20 years of innovation, growth and results, the Axiom Team knows how critical intuitive, cost-effective, and unified e-clinical solutions are for small-to-medium life sciences companies. If your study is still on separate systems, it is not too late to consider shifting to a unified platform. We are here to empower you to strategically manage your studies with fewer resources, a smaller team, and tighter budgets.
Learn more about why Axiom and the Fusion eClinical Suite is the partner of choice of your next study at
axiommetrics.com/
Outsourcing in Clinical Trials Handbook | 35
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
